imatinib mesylate has been researched along with Lymph Node Metastasis in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (37.04) | 29.6817 |
| 2010's | 17 (62.96) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kubo, N; Takeuchi, N | 1 |
| Fancellu, A; Hao, SL; Jiang, LX; Liu, XC; Ma, C; Nin, JY; Porcu, A; Wu, GC; Zheng, HT | 1 |
| Chen, J; Chen, Z; Shen, C; Tang, S; Yang, J; Yao, Y; Yin, X; Yin, Y; Zhang, B | 1 |
| Honda, T; Kabashima, K; Nomura, M; Otsuka, A; Yamashita, C | 1 |
| Kamiryo, Y; Kinjo, M; Okumura, K; Otsubo, S; Shimokama, T | 1 |
| Fukazawa, E; Kobayashi, T; Nakano, Y; Oshima, F; Shiraishi, Y; Takanosu, M; Yamagami, T | 1 |
| Aldabagh, B; Joo, J; Yu, SS | 1 |
| Cao, H; Liu, Q; Qiu, WQ; Shen, YY; Tu, L; Wang, CJ; Wang, M; Xu, J; Zhang, Y | 1 |
| Dang, Y; Gao, J; Li, J; Li, Y; Shen, L; Zou, J | 1 |
| Canda, AE; Nalbant, OA; Ozsoy, Y; Sagol, O | 1 |
| Kong, M; Teng, XD; Wang, YL; Xu, LJ | 1 |
| Liu, XS; Yang, WL; Yu, JR; Yu, JW; Zhang, Q | 1 |
| Ando, N; Harada, K; Kawamura, T; Shibagaki, N; Shimada, S; Yamaguchi, M | 1 |
| Chayama, K; Kitadai, Y; Kodama, M; Ohara, E; Ohnishi, M; Shinagawa, K; Sumida, T; Tanaka, M; Tanaka, S; Yasui, W | 1 |
| Fukumura, D; Huang, P; Huang, Y; Jain, RK; Kamoun, W; Liao, S; Liu, J; Naxerova, K; Samuel, R; Shi, T; Xu, L | 1 |
| Bae, HI; Baek, JH; Bang, YJ; Choi, J; Chung, IJ; Im, SA; Kang, HJ; Kang, YK; Kim, JG; Kim, KM; Kim, WH; Kwon, HC; Lee, JH; Lee, KE; Lee, KH; Park, SH; Park, YS; Ryoo, BY; Ryu, MH; Shin, DB; Song, HS | 1 |
| Bosenberg, M; Curley, DP; Damsky, WE; Dankort, D; Gould Rothberg, BE; McMahon, M; Platt, JT; Rimm, DL; Rosenbaum, LE; Santhanakrishnan, M; Taketo, MM | 1 |
| Wardelmann, E | 1 |
| Rey, S; Russo, A; Russo, MA; Schito, L; Semenza, GL; Tafani, M; Wong, CC; Zhang, H | 1 |
| Bucher, P; Buhler, LH; Egger, JF; Morel, P; Villiger, P | 1 |
| Błasiak, J; Majsterek, I; Pytel, D | 1 |
| Busby, JE; Do, KA; Fan, D; Fidler, IJ; He, J; Kim, SJ; Logothetis, C; Mathew, P; Maya, M; Nakamura, T; Uehara, H; Wang, X; Yazici, S | 1 |
| Ikeda, E; Sakurai, N; Sasou, S; Shibuma, H; Yamauchi, J | 1 |
| Figueiredo, J; Lopes, JM; Moutinho, C; Oliveira, C; Preto, A; Rebocho, AP; Seruca, R; Soares, P; Velho, S | 1 |
| Azim, HA; Elsedewy, E | 1 |
| Heath, J; Kanwar, VS; Krasner, CN; Pearce, JM | 1 |
| Do, KA; Fan, D; Fidler, IJ; Kim, JS; Kim, SJ; Kitadai, Y; Kuwai, T; Langley, RR; Nakamura, T; Sasaki, T; Wang, X | 1 |
8 review(s) available for imatinib mesylate and Lymph Node Metastasis
| Article | Year |
|---|---|
Supraclavicular lymph node metastases from malignant gastrointestinal stromal tumor of the jejunum: A case report with review of the literature.
Topics: Antineoplastic Agents; Biopsy, Needle; Chemotherapy, Adjuvant; Erythrocyte Transfusion; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunum; Lymph Nodes; Lymphatic Metastasis; Male; Melena; Middle Aged; Neck Dissection; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Ultrasonography | 2017 |
[Case of primary retroperitoneal GIST (gastrointestinal stromal tumor) with rapid progression].
Topics: Antineoplastic Agents; Benzamides; Biopsy; Disease Progression; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lymphatic Metastasis; Male; Middle Aged; Piperazines; Pyrimidines; Retroperitoneal Neoplasms; Tomography, X-Ray Computed | 2013 |
Merkel cell carcinoma: current status of targeted and future potential for immunotherapies.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Benzamides; Biomarkers; Carcinoma, Merkel Cell; CD56 Antigen; Electrochemotherapy; Hepatitis A Virus Cellular Receptor 2; Humans; Imatinib Mesylate; Immunotherapy; Immunotherapy, Adoptive; Indazoles; Inhibitor of Apoptosis Proteins; Interferons; Interleukin-12; Interleukin-2; Ipilimumab; Lymphatic Metastasis; Membrane Proteins; Merkel cell polyomavirus; Oligonucleotides, Antisense; Piperazines; Polyomavirus Infections; Prognosis; Programmed Cell Death 1 Receptor; Pyrimidines; Receptors, Somatomedin; Skin Neoplasms; Somatostatin; Sulfonamides; Survivin; Thionucleotides; TOR Serine-Threonine Kinases | 2014 |
[Gastrointestinal stromal tumor of small intestine associated with lymph node metastasis: a report of 2 cases with review of literatures].
Topics: Adult; Antineoplastic Agents; Benzamides; Codon; Exons; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lymphatic Metastasis; Male; Middle Aged; Mutation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines | 2009 |
[Translational research and diagnosis in GIST].
Topics: Adult; Antineoplastic Agents; Benzamides; Disease Progression; DNA Mutational Analysis; Drug Resistance, Neoplasm; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gene Silencing; Germ-Line Mutation; Humans; Imatinib Mesylate; Lymphatic Metastasis; Male; Mitotic Index; Piperazines; Prognosis; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Succinate Dehydrogenase; Transcriptional Activation; Translational Research, Biomedical; Tumor Burden; Young Adult | 2012 |
Management of gastrointestinal stromal tumors: from diagnosis to treatment.
Topics: Algorithms; Antineoplastic Agents; Benzamides; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Immunohistochemistry; Lymphatic Metastasis; Neoplasm Invasiveness; Piperazines; Prognosis; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Stromal Cells; Treatment Outcome | 2004 |
[Tyrosine kinases. New target of anticancer therapy].
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Breast Neoplasms; Female; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphatic Metastasis; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Receptor, ErbB-2; Trastuzumab | 2005 |
Imatinib in the treatment of follicular dendritic sarcoma: a case report and review of literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Cisplatin; Dendritic Cells, Follicular; Deoxycytidine; Follow-Up Studies; Gemcitabine; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
19 other study(ies) available for imatinib mesylate and Lymph Node Metastasis
| Article | Year |
|---|---|
Gastrointestinal stromal tumor of the stomach with axillary lymph node metastasis: A case report.
Topics: Aged; Axilla; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Metastasis; Phenylurea Compounds; Positron-Emission Tomography; Pyridines; Pyrroles; Stomach Neoplasms; Sunitinib; Tomography, X-Ray Computed | 2017 |
Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST).
Topics: Adult; Aged; Antineoplastic Agents; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Preoperative Care; Prognosis; Retrospective Studies; Survival Rate | 2017 |
Successful treatment of metastatic mucosal melanoma with a Del579 c-KIT mutation by imatinib after treatment of anti-PD-1 antibody.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Immunological; Base Sequence; Female; Humans; Imatinib Mesylate; Liver Neoplasms; Lymphatic Metastasis; Melanoma; Mucous Membrane; Programmed Cell Death 1 Receptor; Proto-Oncogene Proteins c-kit; Sequence Deletion; Vulvar Neoplasms | 2019 |
Imatinib responsiveness in canine mast cell tumors carrying novel mutations of c-KIT exon 11.
Topics: Animals; Base Sequence; Benzamides; Dog Diseases; Dogs; Female; Gene Components; Imatinib Mesylate; Lymphatic Metastasis; Male; Mastocytosis; Molecular Sequence Data; Mutation, Missense; Piperazines; Polymerase Chain Reaction; Proto-Oncogene Proteins c-kit; Pyrimidines; Sequence Analysis, DNA; Sequence Deletion; Treatment Outcome | 2014 |
Gastrointestinal stromal tumor: 15-years' experience in a single center.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lymphatic Metastasis; Male; Middle Aged; Mitotic Index; Neoplasm Grading; Neoplasm Invasiveness; Piperazines; Proportional Hazards Models; Pyrimidines; Risk Factors; Tumor Burden; Young Adult | 2014 |
PI3K/AKT/mTOR pathway is activated after imatinib secondary resistance in gastrointestinal stromal tumors (GISTs).
Topics: Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunoenzyme Techniques; Lymphatic Metastasis; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Phosphatidylinositol 3-Kinases; Phosphorylation; Polymerase Chain Reaction; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; PTEN Phosphohydrolase; Signal Transduction; Survival Rate; TOR Serine-Threonine Kinases | 2015 |
Gastrointestinal stromal tumor of the stomach with lymph node metastasis.
Topics: Adult; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Female; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lymph Node Excision; Lymphatic Metastasis; Piperazines; Pyrimidines; Stomach Neoplasms | 2008 |
Gastrointestinal stromal tumor of stomach with inguinal lymph nodes metastasis: a case report.
Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Inguinal Canal; Lymphatic Metastasis; Male; Middle Aged; Piperazines; Pyrimidines; Stomach Neoplasms | 2010 |
Marked response to imatinib mesylate in metastatic acral lentiginous melanoma on the thumb.
Topics: Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Mutation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Skin Neoplasms; Thumb | 2011 |
Expression of platelet-derived growth factor (PDGF)-B and PDGF-receptor β is associated with lymphatic metastasis in human gastric carcinoma.
Topics: Aged; Animals; Benzamides; Blotting, Western; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Immunohistochemistry; Lymphatic Metastasis; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms; Stromal Cells | 2010 |
PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Female; Fluorescent Antibody Technique; Humans; Imatinib Mesylate; Lymphatic Metastasis; Lymphokines; Mice; Mice, Nude; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Receptors, CXCR4; Signal Transduction | 2011 |
Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Exons; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lymphatic Metastasis; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Piperazines; Prognosis; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Retrospective Studies; Survival Rate; Young Adult | 2012 |
β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas.
Topics: Animals; Antigens, Differentiation; Benzamides; beta Catenin; Cell Transformation, Neoplastic; Colorectal Neoplasms; Enzyme Activation; Gene Knockdown Techniques; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Melanocytes; Melanoma, Experimental; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Transgenic; Phosphorylation; Piperazines; Protein Stability; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyrimidines; Signal Transduction; Skin Neoplasms; Splenic Neoplasms; Transcription, Genetic; Tumor Cells, Cultured | 2011 |
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells.
Topics: Benzamides; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Chromatin Immunoprecipitation; Digoxin; Female; Humans; Hypoxia-Inducible Factor 1; Imatinib Mesylate; Immunoblotting; Immunohistochemistry; Luciferases; Lymphangiogenesis; Lymphatic Metastasis; Piperazines; Proto-Oncogene Proteins c-sis; Pyrimidines; RNA, Small Interfering; Transcriptional Activation | 2012 |
Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Blotting, Western; Bone Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endothelial Cells; Fluorescent Antibody Technique; Humans; Imatinib Mesylate; Immunohistochemistry; In Situ Nick-End Labeling; Lymphatic Metastasis; Male; Mice; Mice, Nude; Microcirculation; Neoplasm Transplantation; Neovascularization, Pathologic; Paclitaxel; Phosphorylation; Piperazines; Prostatic Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Random Allocation; Receptors, Platelet-Derived Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Tibia; Tumor Cells, Cultured | 2006 |
[A case of recurrent GIST of the esophagus which completely responded to imatinib mesilate].
Topics: Aged; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Piperazines; Pyrimidines; Remission Induction; Skin Neoplasms | 2007 |
A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation.
Topics: Antineoplastic Agents; Base Sequence; Benzamides; Cell Line, Tumor; Colorectal Neoplasms; DNA Mutational Analysis; Gene Expression; Humans; Imatinib Mesylate; Immunohistochemistry; Lymphatic Metastasis; Molecular Sequence Data; Mutation; Piperazines; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-kit; Proto-Oncogene Proteins p21(ras); Pyrimidines; ras Proteins | 2007 |
Advanced small cell carcinoma of the ovary in a seventeen-year-old female, successfully treated with surgery and multi-agent chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Carcinoma, Small Cell; Celecoxib; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Imatinib Mesylate; Lymph Nodes; Lymphatic Metastasis; Ovarian Neoplasms; Piperazines; Pyrazoles; Pyrimidines; Sulfonamides; Thalidomide; Vinblastine | 2008 |
Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy.
Topics: Animals; Apoptosis; Benzamides; Cell Line, Tumor; Colonic Neoplasms; ErbB Receptors; Humans; Imatinib Mesylate; Immunohistochemistry; Ki-67 Antigen; Lymphatic Metastasis; Male; Mice; Mice, Nude; Piperazines; Platelet Endothelial Cell Adhesion Molecule-1; Purines; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Receptors, Vascular Endothelial Growth Factor; Stromal Cells | 2008 |